Koyfin Home > Directory > Health Care > Acorda Therapeutics > Gross Profit

Acorda Therapeutics Gross Profit Chart (ACOR)

Acorda Therapeutics annual/quarterly Gross Profit from 2010 to 2020. Gross profit is the profit after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Gross profit = Revenue - Cost of Goods Sold.
  • Acorda Therapeutics Gross Profit for the quarter ending June 06, 2020 was $27m a -47.39% decrease of -13m year over year
  • Acorda Therapeutics Gross Profit for the last 12 months ending June 06, 2020 was $133m a -21.81% decrease of -29m year over year
  • Acorda Therapeutics Annual Gross Profit for 2019 was $158m a -137.24% decrease of -216m from 2018
  • Acorda Therapeutics Annual Gross Profit for 2018 was $374m a -27.43% decrease of -103m from 2017
  • Acorda Therapeutics Annual Gross Profit for 2017 was $476m a 13.61% increase of 65m from 2016
Other Income Statement Metrics:
  • Acorda Therapeutics EBITDA for the quarter ending December 12, 2018 was $-14m a 190.76% decrease of -26m year over year
  • Acorda Therapeutics Net Income for the quarter ending December 12, 2018 was $10m a 185.45% increase of 18m year over year
  • Acorda Therapeutics Total Revenue for the quarter ending December 12, 2018 was $69m a -53.52% decrease of -37m year over year
View Chart On Koyfin

Quarterly ACOR Gross Profit Data

06/2020$27m
03/2020$24m
12/2019$42m
09/2019$40m
06/2019$41m
03/2019$35m
12/2018$48m
09/2018$118m
06/2018$123m
03/2018$86m

Annual ACOR Gross Profit Data

2019$158m
2018$374m
2017$476m
2016$411m
2015$400m
2014$321m
2013$270m
2012$248m
2011$239m
2010$155m